Resources
Register to watch>> Join a panel of OM1’s clinical experts in cardiometabolic disease, immunology, and mental health as they explore how Artificial Intelligence (AI) can find phenotypic patterns and unlock insights hidden in real-world data. Extracting as much information as possible from real-world datasets is essential for understanding the complete patient journey. Subtle patterns in[…]
Psychiatric Times May 25, 2023 Leah Kuntz Read the full article>> Presenters at the 2023 APA Annual Meeting compared definitions of treatment-resistant depression. CONFERENCE REPORTER “In 1964, Supreme Court Justice Potter Stewart was asked for his test for obscenity and his response famously was, ‘I know when I see it.’ In the real world and[…]
PM360 MAY 25, 2023 Andrew Matthius Read the full article>> Mental health continues to be a national crisis that is only becoming more prevalent, especially since the pandemic. According to the National Alliance on Mental Illness (NAMI), 22.8% of U.S. adults experienced mental illness in 2021, which represents about 1 in 5 adults or 57.8 million[…]
Business Wire May 24, 2023 Read the full press release>> OM1 now offers a complementary suite of easy-to-digest analytics that give a real-world, 360° view of trends in treatment behaviors and patient outcomes May 24, 2023 09:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–OM1, a leading real-world data, outcomes, and technology company with a focus on chronic[…]
Psychiatric Times May 21, 2023 Carl D. Marci, MD Steven P. Levine, MD Watch the video>> Carl D. Marci, MD, and Steven P. Levine, MD, caught up with Psychiatric Times in this exclusive video after their session, “Treatment Resistant Depression From Multiple Perspectives: Does It Exist?“ Learn more about 3 potential definitions of treatment resistant depression and[…]
